Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial

Last updated: May 27, 2015
Sponsor: University of Liege
Overall Status: Completed

Phase

3

Condition

Oral Facial Pain

Migraine (Adult)

Migraine (Pediatric)

Treatment

N/A

Clinical Study ID

NCT02122237
CB-1289
  • Ages 18-65
  • All Genders

Study Summary

Cathodal tDCS decreases the excitability of the cerebral cortex and its daily application during intercritical phase, may have a therapeutic effect in chronic migraine.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse

Exclusion

Exclusion Criteria:

  • others diseases or contraindications to tDCS (epilepsy, pacemaker, metal prosthetics)

Study Design

Total Participants: 14
Study Start date:
September 01, 2013
Estimated Completion Date:
September 30, 2014

Study Description

During the interictal phase, the cerebral cortex is characterised by a hyperresponsiveness to repeated sensory stimuli, manifested by a lack of habituation or adaptation of cortical responses. Lack of habituation has been shown in the visual cortex in studies of visual evoked potentials (VEP) during the interictal period and it is possibly explained by a reduction in the cortical pre-activation level due to thalamo-cortical dysrhythmia. Just before and during the migraine attack, cortical reactivity changes drastically: habituation is restored and the amplitude increases. In chronic migraine (headache occurring on 15 or more days per month for more than 3 months with features of migraine headache on at least 8 days per month), VEPs habituate normally like those recorded during attacks of episodic migraine, but have in addition an increased amplitude in the 1st block of responses. Chronic migraine was therefore compared to a "never ending migraine attack" accompanied by cortical hypersensitivity.

In this study the investigators aim to demonstrate that cathodal tDCS over the visual cortex with simultaneous anodal tDCS over the left dorsolateral prefrontal cortex is able: 1) to reduce cortical hypersensitivity and habituation as assessed by VEPs and contact heat evoked nociceptive potentials (CHEPS), as well as to decrease pain perception assessed by quantitative sensory testing (QST) and the nociceptive blink reflex (nBR); 2) to decrease headache and migraine frequency.

Connect with a study center

  • Roberta Baschi

    Liège, 4000
    Belgium

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.